2022 journal article

Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by Fc epsilon RI beta and the Potential Impact of Fc epsilon RI beta Splicing in Allergic Inflammation


By: G. Arthur n & G. Cruse n

co-author countries: United States of America 🇺🇸
author keywords: mast cell; IgE receptor; Fc epsilon RI beta; antisense therapy; allergy; asthma; exon skipping
MeSH headings : Alternative Splicing; Animals; Biomarkers; Cell Degranulation / genetics; Cell Degranulation / immunology; Disease Susceptibility; Gene Expression Regulation; Humans; Hypersensitivity / diagnosis; Hypersensitivity / etiology; Hypersensitivity / metabolism; Hypersensitivity / therapy; Mast Cells / immunology; Mast Cells / metabolism; RNA Splicing; Receptors, IgE / chemistry; Receptors, IgE / genetics; Receptors, IgE / metabolism; Signal Transduction; Structure-Activity Relationship
Source: Web Of Science
Added: February 7, 2022

Mast cells are tissue-resident immune cells that function in both innate and adaptive immunity through the release of both preformed granule-stored mediators, and newly generated proinflammatory mediators that contribute to the generation of both the early and late phases of the allergic inflammatory response. Although mast cells can be activated by a vast array of mediators to contribute to homeostasis and pathophysiology in diverse settings and contexts, in this review, we will focus on the canonical setting of IgE-mediated activation and allergic inflammation. IgE-dependent activation of mast cells occurs through the high affinity IgE receptor, FcεRI, which is a multimeric receptor complex that, once crosslinked by antigen, triggers a cascade of signaling to generate a robust response in mast cells. Here, we discuss FcεRI structure and function, and describe established and emerging roles of the β subunit of FcεRI (FcεRIβ) in regulating mast cell function and FcεRI trafficking and signaling. We discuss current approaches to target IgE and FcεRI signaling and emerging approaches that could target FcεRIβ specifically. We examine how alternative splicing of FcεRIβ alters protein function and how manipulation of splicing could be employed as a therapeutic approach. Targeting FcεRI directly and/or IgE binding to FcεRI are promising approaches to therapeutics for allergic inflammation. The characteristic role of FcεRIβ in both trafficking and signaling of the FcεRI receptor complex, the specificity to IgE-mediated activation pathways, and the preferential expression in mast cells and basophils, makes FcεRIβ an excellent, but challenging, candidate for therapeutic strategies in allergy and asthma, if targeting can be realized.